Multiple Endocrine Neoplasia Type 1

Reviews in Endocrine and Metabolic Disorders

Volumn 1, Issue 4, 2000, Pages 275-282

  Brandi, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Hyperparathyroidism; MEN 1; Menin

Indexed keywords

ANIMAL; GENETICS; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; REVIEW;

ANIMALS; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1;

EID: 0034331354     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026562217102     Document Type: Article

References (42)

1. DeLellis RE, Dayal Y, Tischler AS, Lee AK, Wolfe HJ. Multiple endocrine neoplasia (men) syndromes: cellular origins and interrelationships. Int Rev Exp Pathol 1986;28:163-215.
2. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA. Familial multiple endocrine neoplasia type i: a new look at pathophysiology. Endocr Rev 1987;8:391-405.
3. DeLellis RA. Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features. Lab Invest; 1995;72:494-505.
4. Komminoth P. Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997. Verh Dtsch Ges Pathol 1997;81:125-138.
5. Komminoth P, Heitz PU, Kloppel G. Pathology of MEN-1: morphology, clinicopathologic correlations and tumour development. J Intern Med 1998;243:455-464.
6. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-87.
7. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995;95:2047-2053.
8. Marx SJ. Multiple endocrine neoplasia type 1. In: Vogelstein B, Kinzler KW, eds. The Genetic Basis of Human Cancer. New York: McGraw Hill, 1998;489-506.
9. Skarulis MC. Clinical expressions of MEN1 at NIH. Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann Int Med 1998;129:486-487.
10. Marx SJ, Menczel J, Campbell G, Aurbach GD, Spiegel AM, Norton JA. Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. Clin Endocrinol 1991;35:521-526.
11. Rizzoli R, Green J III, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long term followup of serum calcium after parathyroidectomy. Am J Med 1985;78:468-474.
12. Doppman JL. Tumor localization in multiple endocrine neoplasia type 1. Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann Int Med 1998;129:487-488.
13. Darling TN, Skarulis MC, Steinberg SM, Marx SJ, Spiegel AM, Turner M. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 1997;133:853-857.
14. Teh BT, McArdle J, Chan SP, Menon J, Hartley L, Pullan P, Ho J, Khir A, Wilkinson S, Larsson C, Cameron D, Shepherd J. Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 1997;76:21-29.
15. Bordi C, Falchetti A, Azzoni C, D'Ada T, Canavese G, Guariglia A, Santini D, Tomassetti P, Brandi ML. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type 1. Am J Surg Pathol 1997;21:1075-1082.
16. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Jr, Norton JA. Lethality of multiple endocrine neoplasia type 1. World J Surg 1998;22:581-658.
17. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-407.
18. Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS, Chandrasekharappa SC. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Rec. Prog Horm Res 1999;54:397-438.
19. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, Chandrasekharappa SC. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci USA 1998;95:1630-1634.
20. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 1999;96:143-152.
21. Guru SC et al. 7th Int'l MEN workshop, 1999.
22. Rahmsdorf HJ. Jun: transcription factor and oncoprotein. J Mol Med 1996;74:725-747.
23. Angel PE, Herrlich PA. General structure of AP1 subunits and characteristics of the Jun proteins. 1994;3-14.
24. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, Green JS, Guru SC, Manickam P, Olufemi SE, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997;6:1169-1175.
25. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S, Yaniv M. Mouse jund negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 1994;76:747-760.
26. Mechta F, Lallemand D, Pfarr CM, Yaniv M. Transformation by ras modifies AP1 composition and activity. Oncogene 1997;14:837-847.
27. Bassett JH, Rashbass P, Harding B, Forbes SA, Pannett AA, Thakker RV. Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1. J Bone Mineral Res 1999;14:3-10.
28. Guru SC, Crabtree JS, Brown KD, Dunn KJ, Manickam P, Prasad NB, Wangsa D, Burns AL, Spiegel AM, Marx SJ, Pavan WJ, Colins FS, Chandrasekharappa SC. Isolation, genomic organization, and expression analysis of Men 1, the murine homolog of the MEN1 gene. Mamm Genome 1999;10:592-596.
29. Stewart C, Parente F, Piehl F, Farnebo F, Quincey D, Silins G, Bergman L, Carle GF, Lemmens I, Grimmond S, Xian CZ, Khodei S, Teh BT, Lagercrantz J, Siggers P, Calender A, Van de Vem V, Kas K, Weber G, Hayward N, Gaudray P, Larsson C. Characterization of the mouse Men1 gene and its expression during development. Oncogene 1998;17:2485-2493.
30. Agarwal SK, Heppner C, Collins R, Park S, Saggar S, Knapp JL, Bilimoria KY, Spiegel AM, Marx SJ, Burns AL, Guru SC, Erdos M, Collins FS, Chandrasekharappa SC. 7th Int'l MEN workshop, 1999.
31. Bassett JH et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1998;6:232-244.
32. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV. Clinical studies of multiple endocrine neoplasia type 1. Q J Med 1996;89:653-669.
33. Thakker RV. Multiple endocrine neoplasia-syndromes of the twentieth century. J Clin Endo Metab 1998;83:2617-2620.
34. The European Consortium on MEN1. Hum Mol Genet 1997;6:1177-1183.
35. Thakker RV. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin Endocrinol 1993;38:1-14.
36. The European Consortium on MEN 1: Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1997;6:1169-1175.
37. Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J, Buisson N, Waterlot C, Bauters C, Porchet N, Aubert JP, Emy P, Cadiot G, Delemer B, Chabre O, Niccoli P, Leprat F, Duron F, Emperauger B, Cougard P, Goudet P, Sarfati E, Riou JP, Guichard S, Rodier M, Meyrier A, Caron P, Vantyghem M, Lenoir G, Gaudray P, Proye C, ConteDevolux B, Chanson P, Shugart YY, Goldgar D, Murat A, Calender A. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 1998;63:455-467.
38. Teh BT, Kytola S, Farnebo F, Bergman L, Wong FK, Weber G, Hayward N, Larsson C, Skogseid B, Beckers A, Phelan C, Edwards M, Epstein M, Alford F, Hurley D, Grimmond S, Silins G, Walters M, Stewart C, Cardinal J, Khodaei S, Parente F, Tranebjaerg L, Jorde R, Menon J, Khyr A, Tan TT, Chan SP, Zaini A, Khalid BAK, Sandelin K, Thompson N, Brandi ML, Warth M, Stock J, Leisti J, Cameron D, Shepherd JJ, Oberg K, Nordenskjöld M, Salmela P. Mutation Analysis of the MEN1 Gene in Multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998;83:2621-2626.
39. Sunita K, Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ, Burns AL. Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription. Cell 1999;96:143-152.
40. Calender A. Genetic testing in multiple endocrine neoplasia and related syndromes. Forum 1998;8:146-159.
41. Martin P, Bergmann P, Gillet C, Fuss M, Kinnaert P, Corvilain J, van Geertruyden J. Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 1986;146:689-691.
42. Sivula A, Pelkonen R. Long-term health risk of primary hyperparathyroidism: the effect of surgery. Ann Med 1996;28:95-100.